Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Total Current Liabilities (2019 - 2025)

Korro Bio (KRRO) has disclosed Total Current Liabilities for 6 consecutive years, with $14.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities rose 7.55% year-over-year to $14.6 million, compared with a TTM value of $14.6 million through Sep 2025, up 7.55%, and an annual FY2024 reading of $15.0 million, down 23.22% over the prior year.
  • Total Current Liabilities was $14.6 million for Q3 2025 at Korro Bio, down from $17.2 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $22.0 million in Q1 2023 and bottomed at $8.3 million in Q2 2023.
  • Average Total Current Liabilities over 5 years is $13.9 million, with a median of $12.9 million recorded in 2025.
  • The sharpest move saw Total Current Liabilities crashed 78.06% in 2021, then soared 123.92% in 2023.
  • Year by year, Total Current Liabilities stood at $11.4 million in 2021, then dropped by 23.87% to $8.7 million in 2022, then skyrocketed by 123.92% to $19.5 million in 2023, then decreased by 23.22% to $15.0 million in 2024, then dropped by 2.15% to $14.6 million in 2025.
  • Business Quant data shows Total Current Liabilities for KRRO at $14.6 million in Q3 2025, $17.2 million in Q2 2025, and $12.9 million in Q1 2025.